Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bionano Genomics Inc (BNGO)

Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,889
  • Shares Outstanding, K 101,993
  • Annual Sales, $ 36,120 K
  • Annual Income, $ -232,490 K
  • EBIT $ -97 M
  • EBITDA $ -7 M
  • 60-Month Beta 2.28
  • Price/Sales 0.55
  • Price/Cash Flow N/A
  • Price/Book 0.35
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.12
  • Most Recent Earnings $-0.32 on 11/14/24
  • Next Earnings Date 11/13/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 343.65% ( -45.03%)
  • Historical Volatility 78.85%
  • IV Percentile 89%
  • IV Rank 54.40%
  • IV High 611.09% on 12/02/24
  • IV Low 24.63% on 09/19/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 66
  • Volume Avg (30-Day) 237
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 44,028
  • Open Int (30-Day) 42,214

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.96
  • Growth Rate Est. (year over year) +104,162.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1950 unch
on 12/20/24
0.2809 -30.58%
on 12/02/24
-0.0144 (-6.88%)
since 11/20/24
3-Month
0.1950 unch
on 12/20/24
0.5086 -61.66%
on 09/27/24
-0.2105 (-51.91%)
since 09/20/24
52-Week
0.1950 unch
on 12/20/24
2.2700 -91.41%
on 12/28/23
-1.4250 (-87.96%)
since 12/20/23

Most Recent Stories

More News
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal

BNGO : 0.1950 (-2.74%)
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy

BNGO : 0.1950 (-2.74%)
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript

BNGO earnings call for the period ending September 30, 2024.

BNGO : 0.1950 (-2.74%)
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

BNGO : 0.1950 (-2.74%)
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024

BNGO : 0.1950 (-2.74%)
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

BNGO : 0.1950 (-2.74%)
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

BNGO : 0.1950 (-2.74%)
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

BNGO : 0.1950 (-2.74%)
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma

BNGO : 0.1950 (-2.74%)
Bionano Announces Preliminary 3Q 2024 Revenues and Cash

BNGO : 0.1950 (-2.74%)

Business Summary

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San...

See More

Key Turning Points

3rd Resistance Point 0.2100
2nd Resistance Point 0.2070
1st Resistance Point 0.2010
Last Price 0.1950
1st Support Level 0.1920
2nd Support Level 0.1890
3rd Support Level 0.1830

See More

52-Week High 2.2700
Fibonacci 61.8% 1.4773
Fibonacci 50% 1.2325
Fibonacci 38.2% 0.9876
Last Price 0.1950
52-Week Low 0.1950

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar